- Home
- MFIN vs XBIT Comparison
MFIN vs XBIT Comparison
Compare MFIN & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFIN
- XBIT
- Stock Information
- Founded
- MFIN 1995
- XBIT 2005
- Country
- MFIN United States
- XBIT United States
- Employees
- MFIN N/A
- XBIT N/A
- Industry
- MFIN Finance: Consumer Services
- XBIT Pharmaceuticals and Biotechnology
- Sector
- MFIN Finance
- XBIT Health Care
- Exchange
- MFIN Nasdaq
- XBIT Nasdaq
- Market Cap
- MFIN 190.0M
- XBIT 194.5M
- IPO Year
- MFIN 1996
- XBIT 2015
- Fundamental
- Price
- MFIN $9.07
- XBIT $3.85
- Analyst Decision
- MFIN
- XBIT
- Analyst Count
- MFIN 0
- XBIT 0
- Target Price
- MFIN N/A
- XBIT N/A
- AVG Volume (30 Days)
- MFIN 73.1K
- XBIT 103.6K
- Earning Date
- MFIN 02-18-2025
- XBIT 11-13-2024
- Dividend Yield
- MFIN 4.86%
- XBIT N/A
- EPS Growth
- MFIN N/A
- XBIT N/A
- EPS
- MFIN 1.69
- XBIT N/A
- Revenue
- MFIN $293,257,000.00
- XBIT N/A
- Revenue This Year
- MFIN N/A
- XBIT N/A
- Revenue Next Year
- MFIN $10.95
- XBIT N/A
- P/E Ratio
- MFIN $5.42
- XBIT N/A
- Revenue Growth
- MFIN 18.48
- XBIT N/A
- 52 Week Low
- MFIN $6.48
- XBIT $3.51
- 52 Week High
- MFIN $10.50
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- MFIN 38.98
- XBIT 30.00
- Support Level
- MFIN $9.09
- XBIT $3.72
- Resistance Level
- MFIN $9.56
- XBIT $4.67
- Average True Range (ATR)
- MFIN 0.33
- XBIT 0.49
- MACD
- MFIN -0.07
- XBIT -0.04
- Stochastic Oscillator
- MFIN 25.22
- XBIT 10.81
About MFIN Medallion Financial Corp.
Medallion Financial Corp is a finance company that originates and services loans in various industries. Its operating segments include recreation, home improvement, commercial lending, medallion lending and Corporate and Other Investments. The company generates maximum revenue from the Recreation segment.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.